EXAMINE THIS REPORT ON RESTORIL CAPSULES

Concomitant utilization of oxycodone HCl with CYP3A4 inducers or discontinuation of the CYP3A4 inhibitor could lower oxycodone plasma concentrations, decrease opioid efficacy or, perhaps, produce a withdrawal syndrome in a affected person who experienced developed Actual physical dependence to oxycodone.Notify your health and fitness care qualified